1. Health and Safety Executive. Chronic Obstructive Pulmonary Disease (COPD) in Great Britain (2013). Available at
www.hse.gov.uk/statistics/causdis/copd/
. Accessed on 11 October 2015.
2. National Institute for Health and Care Excellence. NICE pathways. COPD. Available at
http://pathways.nice.org.uk/pathways/chronic-obstructive-pulmonary-disease#content=view-node%3Anodes-referral-for-specialist-advice
. Accessed on 11 October 2016.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Available at
http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/
. Accessed on 11 October 2016.
4. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. Available at
http://guidance.nice.org.uk/CG101/Guidance/pdf/English
. Accessed on 11 October 2016.
5. Price, D., Yawn, B., Brusselle, G. & Rossi, A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim. Care Respir. J. 22, 92–100 (2013).